| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 500 | $379.39 | $189,695.00 | -7.6% | -2.8% | -25.5% | |
| Jun 15, 2023 | XGN Exagen Inc. | Tullis James L L73 | 10% Owner | Buy | 167 | $3.11 | $519.45 | - | -27.3% | -39.1% | |
| Jun 15, 2023 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 2,766 | $37.55 | $103,863.30 | -39.6% | -14.8% | -20.2% | |
| Jun 14, 2023 | IMDX Insight Molecular Diagnostics Inc. | Kingsley Alfred D | Director | Buy | 30,000 | $0.21 | $6,447.00 | +6.8% | -23.9% | -38.0% | |
| Jun 13, 2023 | NTRA Natera, Inc. | Chapman Rowan E52 | Director | Sell | 1,767 | $50.58 | $89,366.03 | -17.0% | +7.6% | +122.0% | |
| Jun 13, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 903 | $6.49 | $5,860.29 | -13.3% | -30.6% | +297.1% | |
| Jun 12, 2023 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 828 | $6.49 | $5,373.55 | -23.0% | -29.3% | +300.6% | |
| Jun 12, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 845 | $6.49 | $5,483.88 | -9.6% | -29.3% | +300.6% | |
| Jun 12, 2023 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 2,674 | $6.49 | $17,353.73 | -11.8% | -29.3% | +300.6% | |
| Jun 9, 2023 | GH Guardant Health, Inc. | Kalia Kumud61 | Chief Information Officer | Buy | 2,981 | $32.71 | $97,498.02 | +44.8% | +7.4% | -12.8% | |
| Jun 9, 2023 | EXAS Exact Sciences Corp | Doyle James Edward75 | Director | Sell | 1,402 | $90.51 | $126,895.02 | -2.5% | -10.2% | -51.1% | |
| Jun 9, 2023 | EXAS Exact Sciences Corp | Zanotti Katherine S50 | Director | Sell | 3,027 | $90.51 | $273,973.77 | -4.5% | -10.2% | -51.1% | |
| Jun 8, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 49,347 | $220.85 | $10,898,284.95 | -0.8% | +20.8% | +81.0% | |
| Jun 8, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 49,347 | $220.85 | $10,898,284.95 | -0.8% | +20.8% | +81.0% | |
| Jun 8, 2023 | EXAS Exact Sciences Corp | Herriott James75 | General Counsel | Sell | 1,300 | $90.00 | $117,000.00 | -15.2% | -9.4% | -52.6% | |
| Jun 8, 2023 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 45,000 | $31.05 | $1,397,200.00 | -4.9% | -2.3% | +93.5% | |
| Jun 7, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 6,000 | $49.12 | $294,721.78 | -0.5% | +19.9% | +120.4% | |
| Jun 7, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 169,005 | $222.15 | $37,544,581.46 | -1.3% | +19.3% | +81.4% | |
| Jun 7, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 169,005 | $222.15 | $37,544,581.46 | -1.3% | +19.3% | +81.4% | |
| Jun 6, 2023 | BIO Bio-Rad Laboratories, Inc. | Ramalingam Ajit59 | SVP, Chief Accounting Officer | Sell | 198 | $368.30 | $73,052.72 | -52.3% | +3.1% | -22.0% | |
| Jun 5, 2023 | IQV Iqvia Holdings Inc. | Knightly Kevin C57 | See Remarks | Sell | 5,820 | $201.89 | $1,174,999.80 | -100% | +8.3% | +6.5% | |
| Jun 5, 2023 | CSTL Castle Biosciences Inc | Goldberg Ellen | Director | Buy | 4,800 | $14.38 | $69,004.00 | +44.3% | +64.0% | +101.7% | |
| Jun 2, 2023 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 1,000 | $40.30 | $40,296.10 | -0.1% | -18.8% | -48.8% | |
| Jun 2, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,819 | $8.13 | $22,911.42 | -0.5% | +14.5% | +60.0% | |
| Jun 2, 2023 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,433 | $40.30 | $57,744.31 | -0.3% | -18.8% | -48.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.